title: Experience with tacrolimus as primary immunosuppressor in pediatric liver transplant.
authors.affiliation: Pediatric Surgery Department, Hospital Vall d'Hebrón, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Asensio
authors.forename: R
authors.initials: R
authors.lastname: Chavez
authors.forename: J
authors.initials: J
authors.lastname: Ortega
authors.forename: J
authors.initials: J
authors.lastname: Iglesias
authors.forename: R
authors.initials: R
authors.lastname: Charco
authors.forename: C
authors.initials: C
authors.lastname: Margarit
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus; D008775:Methylprednisolone